Impact1

Overview

Each year, the US Food and Drug Administration (FDA) approves far fewer health technologies for use in children than adults. This means that pediatric specialists do not always have access to the advanced tools they need to address the unique healthcare needs of their small, vulnerable patients.

Stanford launched Impact1 to improve the health, safety, and quality of life of pediatric patients and pregnant women. We do this by accelerating the development and availability of high-value, high-impact pediatric health technologies.

The program leverages Stanford Biodesign’s need-driven innovation process to accomplish this goal. It benefits from access to world-renowned clinicians and engineers at Stanford, as well as an unparalleled network of Silicon Valley experts in medical device product development, regulatory affairs, intellectual property, reimbursement, and commercialization.

SIGN-UP TO RECEIVE IMPACT1 UPDATES

GET INVOLVED
Stanford Innovator’s Forum

Every month, innovators from around the world join Stanford’s Innovators Forum to share their projects and receive feedback. We welcome projects at any stage, from idea to commercialization, that aim to improve pediatric or maternal health. Feedback and advising is provided by experts in the field with diverse skillsets and backgrounds spanning medicine, engineering, finance, reimbursement, and more.

The meeting is open to the public, so please join us – whether you have a project of your own, resources to offer, or simply an interest in pediatric and maternal care. We look forward to a lively discussion.

Sign-Up to Present Sign-Up as a Participant